dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pons Delgado, Mònica |
dc.contributor.author | Rivera Esteban, Jesus Manuel |
dc.contributor.author | Manzano Nuñez, Ramiro |
dc.contributor.author | Bañares Sanchez, Juan |
dc.contributor.author | Bermúdez Ramos, María |
dc.contributor.author | Salcedo Allende, Maria Teresa |
dc.contributor.author | Castells Fusté, Lluis |
dc.contributor.author | Minguez Rosique, Beatriz |
dc.contributor.author | Pericàs Pulido, Juan Manuel |
dc.contributor.author | Vargas Blasco, Victor Manuel |
dc.contributor.author | Augustin Recio, Salvador |
dc.date.accessioned | 2022-09-07T11:45:21Z |
dc.date.available | 2022-09-07T11:45:21Z |
dc.date.issued | 2022-05 |
dc.identifier.citation | Pons M, Rivera-Esteban J, Manzano R, Bañares J, Bermúdez M, Vargas V, et al. Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD. J Clin Med. 2022 May;11(9):2466. |
dc.identifier.issn | 2077-0383 |
dc.identifier.uri | https://hdl.handle.net/11351/8050 |
dc.description | Carcinoma hepatocel·lular; Elastografia transitòria |
dc.description.sponsorship | The study was conducted in accordance with the Declaration of Helsinki and approved by the Vall d’Hebron University Hospital Campus Institutional Review Board (study protocol code PR(AG)626/2021). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Clinical Medicine;11(9) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Cirrosi hepàtica |
dc.subject | Fetge - Càncer - Diagnòstic |
dc.subject | Esteatosi hepàtica |
dc.subject.mesh | Carcinoma, Hepatocellular |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Non-alcoholic Fatty Liver Disease |
dc.subject.mesh | Liver Cirrhosis |
dc.title | Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jcm11092466 |
dc.subject.decs | carcinoma hepatocelular |
dc.subject.decs | /diagnóstico |
dc.subject.decs | esteatosis hepática no alcohólica |
dc.subject.decs | cirrosis hepática |
dc.relation.publishversion | https://doi.org/10.3390/jcm11092466 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pons M, Manzano R, Bañares J, Bermúdez M] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Rivera-Esteban J] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Vargas V, Castells L, Mínguez B] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Digestivas y Hepáticas (CIBERehd), 28029 Madrid, Spain. [Salcedo-Allende MT] Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Augustin S, Pericàs JM] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Digestivas y Hepáticas (CIBERehd), 28029 Madrid, Spain |
dc.identifier.pmid | 35566592 |
dc.identifier.wos | 000796146700001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |